openPR Logo
Press release

Chlamydia Infection Diagnostic and Therapeutic Market: Global Industry Analysis 2023

05-18-2017 03:51 PM CET | Health & Medicine

Press release from: Transparency Market Research

Chlamydia Infection Diagnostic and Therapeutic Market: Global

Chlamydia is a common sexually transmitted infection caused by bacterium Chlamydia trachomatis. Chlamydia is among the most prevalent sexually transmitted disease (STDs) and according to Centers for Disease Control and Prevention (CDC), it comprises of largest proportion of all STDs reported in the United States since 1994. In 2012, a total of 1.4 million cases of Chlamydia infection were reported to CDC in 50 states and the District of Columbia.

Overall the case rate among males in 2012 rose by 3.2% during 2011-2012 which is approximately half the case rate reported in females. Chlamydia infection among women is generally asymptomatic. However the disease if left untreated can develop into pelvic inflammatory disease (PID) which is a major cause of infertility, ectopic pregnancy, and chronic pelvic pain. Similar to other STDs, chlamydia infection might facilitate the transmission of human immunodeficiency virus (HIV) infection.

Obtain Report Details @ http://www.transparencymarketresearch.com/chlamydia-infection-diagnostic-therapeutic-market.html

Moreover, pregnant women infected with chlamydia can pass the infection to their infants during delivery, potentially resulting in neonatal ophthalmia and pneumonia. In Europe there are more than 250,000 new cases are reported each year and women below 24 years in Europe have highest number of infection. In 2012, National Health Service, U.K., 206,912 people were tested positive for Chlamydia in England of which 64% were below 25 years of age.

Among women, symptoms of chlamydia include abnormal vaginal discharge, painful periods and abdominal pain with fever. Additionally itching and burning around vagina and mild pain during urination. Whereas among men symptom such as cloudy discharge, painful urination, burning around genital area and swelling of testicles are commonly found. Commonly used drugs for treating chlamydia include Amoxil, Doryx, Doxycycline, Erythrocin, Floxin, Gantrisin, Trimox, Zithromax and others.

Some of the emerging diagnostic techniques in global Chlamydia Infection Diagnostic and Therapeutic market comprise molecular diagnostic, immunoassays, monoclonal antibodies, flow cytometry and gel moicrodroplet based testing. Major drivers for the growth of the market include increasing collaboration agreement with distributors, manufacturers and universities pertaining to manufacturing and research activities have escalated the market in past few years. Pipelined drugs in the market include CEL-1000, Cyanovirin-N, GEN-001, acALY18 and others.

Geographically the market for chlamydia is predominated by developed regions such as the United States and Europe. Major contributors to the growth of these markets include intense research funding and government interventions for developing cheap and affordable medications for sexually transmitted diseases under Affordable CARE Act.

Availability of advanced diagnostic centers, clinics and hospitals has also contributed towards the growth and development of market in past one decade. Asia Pacific and Rest of the World market is potentially a lucrative market and has fastest growth rate as compared to other regions pertaining to increasing sexually transmitted diseases incidences and lack of appropriate diagnostic and care centers for sexually transmitted infection/ diseases especially in the under developed parts of Asia-Pacific and Rest of the World is restraining the growth of the market.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8212

Approximately 43 million new cases of chlamydia are reported in Southeast Asian region. Whereas according to the 1999 World Health Organization report prevalence rate of chlamydia in Western Pacific region ranges from 5.7% in Thailand up to 17% in India. The aforementioned data clearly depicts the latent growth potential for drug and diagnostic companies manufacturing chlamydia related products.

Some of the key players operating in global chlamydia infection diagnostic and therapeutic market include: Abbott Laboratories, Danaher Corporation, bioMerieux, DiaSorin SpA, NANOGEN Biopharmaceutical, Siemens AG, Thermo Fisher Scientific, Novartis Diagnostics, Fujirebio Diagnostics, Inc. and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chlamydia Infection Diagnostic and Therapeutic Market: Global Industry Analysis 2023 here

News-ID: 541090 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Chlamydia

Global Chlamydia Diagnostic Testing Market Analysis by 2020-2025
Scope of the Report: The global Chlamydia Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation Chlamydia Diagnostic Testing market is split by Type and by Application. For the period 2015-2025, the growth
Chlamydia Infections-Pipeline Review H2 2018
Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex partners and history of prior sexually transmitted infection. Treatment includes antibiotics and pain medicine. Report Highlights Publisher's Pharmaceutical and Healthcare latest pipeline guide Chlamydia Infections-Pipeline Review, H2 2018,
Chlamydia Infections Therapeutic Pipeline Market Review, H1 2018
Summary Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex partners and history of prior sexually transmitted infection. Treatment includes antibiotics and pain medicine. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Chlamydia Infections - Pipeline Review, H1 2018,
Chlamydia Diagnostics Market To Be At Forefront By 2019
Some of the major players in Chlamydia Diagnostic Market include Abbott Laboratories, Bio-Rad, Novartis Diagnostics, Roche, Wallac, ID Biomedical and others. Chlamydia is one of the most widespread sexually transmitted diseases. It is caused by bacteria named Chlamydomonas trachomatis. This disease is more common in females as compared to male population. In addition, the disease is more prevalent in people who are older than 25 years due to multiple sex and
Chlamydia Infections Market Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chlamydia Infections - Pipeline Review, H2 2017, provides an overview of the Chlamydia Infections (Infectious Disease) pipeline landscape. Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharge from the penis or vagina, pain in the lower abdomen, bleeding between periods and pain and swelling around the testicles. Predisposing factors include age, multiple sex
Chlamydia Infections Global Clinical Trials Review H1 2017
ReportsWeb.com published “Chlamydia Infections Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's clinical trial report "Chlamydia Infections Global Clinical Trials Review H1 2017" provides an overview of Chlamydia Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Chlamydia Infections.